{"gene":"PABPN1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1998,"finding":"Short GCG expansions in the PABPN1 gene expand the N-terminal polyalanine tract from 10 to 12–17 alanines, causing oculopharyngeal muscular dystrophy (OPMD) and leading to accumulation of nuclear filament inclusions in skeletal muscle fibres.","method":"Genetic linkage and mutation analysis in 144 OPMD families","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — foundational mutation discovery, replicated across many subsequent studies","pmids":["9462747"],"is_preprint":false},{"year":2000,"finding":"PABPN1 (PABP2) bound to poly(A) RNA forms both linear filaments and discrete-sized, compact oligomeric particles (~21 nm diameter) whose maximum size corresponds to poly(A) tails of 200–300 nt, consistent with in vivo poly(A) tail length; filament-to-particle equilibrium is sensitive to ionic strength.","method":"Electron microscopy and scanning force microscopy of PABP2·poly(A) complexes; gel mobility shift and nitrocellulose filter binding assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — direct structural characterization by multiple orthogonal imaging methods with functional correlation","pmids":["10731412"],"is_preprint":false},{"year":2000,"finding":"PABPN1 localizes to nuclear speckles strictly as a consequence of its binding to poly(A) RNA; this localization is independent of nuclear import per se but requires functional poly(A) binding (mutants with reduced poly(A) affinity fail to localize to speckles).","method":"Inhibition of transcription/poly(A) synthesis at end of mitosis; PABPN1 mutant expression in HeLa cells; immunofluorescence","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — multiple perturbations (transcription inhibition, poly(A) synthesis block, RNA-binding mutants) with consistent localization readout","pmids":["10825302"],"is_preprint":false},{"year":2000,"finding":"Expanded PABPN1 (mutant PABP2) protein accumulates exclusively in intranuclear aggregates in muscle fibers of OPMD patients, not in normal controls, suggesting molecular modification (e.g., arginine dimethylation at residues 271–291 may differ in mutant protein).","method":"Immunofluorescence with peptide antiserum recognizing residues 271–291 on patient muscle biopsies","journal":"Muscle & nerve","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization in patient tissue with functional implication, single lab","pmids":["11003790"],"is_preprint":false},{"year":2000,"finding":"Expression of mutated PABP2 (expanded polyalanine) cDNA in COS-7 cells is sufficient to induce its accumulation as intranuclear inclusions, demonstrating that the polyalanine expansion directly drives nuclear aggregate formation.","method":"Transfection of normal vs. expanded PABP2 constructs in COS-7 cells; immunofluorescence","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 — direct cell model experiment establishing sufficiency of expanded polyalanine for inclusion formation, replicated by multiple subsequent studies","pmids":["11079546"],"is_preprint":false},{"year":2001,"finding":"PABPN1 oligomerization is mediated by two oligomerization domains (ODs); inactivating either OD by 6–8 amino acid deletions prevents mutant PABPN1-induced nuclear protein aggregation and significantly reduces associated cell death in COS-7 cells.","method":"Deletion mutagenesis of ODs in mutant PABPN1; expression in COS-7 cells; immunofluorescence; cell death assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis-based dissection of oligomerization domains with direct cellular phenotypic readout","pmids":["11689481"],"is_preprint":false},{"year":2003,"finding":"PABPN1 interacts with hnRNP A1 and hnRNP A/B; when co-expressed with expanded PABPN1 in COS-7 cells, these proteins co-localize with mutant PABPN1 in insoluble intranuclear aggregates, and hnRNP A1 is sequestered in OPMD nuclear inclusions in patient muscle.","method":"Yeast two-hybrid screen; GST pull-down; co-immunoprecipitation; co-localization in OPMD patient muscle and cellular model","journal":"The Canadian journal of neurological sciences","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding confirmed by multiple methods (Y2H, pull-down, co-IP) and verified in patient tissue","pmids":["12945950"],"is_preprint":false},{"year":2003,"finding":"Polyalanine-expanded PABPN1 N-terminal fragments form amyloid-like fibrils with antiparallel beta-sheet structure; expansion of poly-L-alanine to maximal OPMD length increases alpha-helical content and fibril formation that can be seeded.","method":"Recombinant protein production; ThT fluorescence; CD spectroscopy; electron microscopy; seeding experiments","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with structural characterization; biophysical properties linked to disease-causing expansions","pmids":["14627730"],"is_preprint":false},{"year":2003,"finding":"PABPN1 is associated with RNA polymerase II along the chromatin axis and accompanies the released mRNA ribonucleoprotein (mRNP) to the nuclear pore, but is largely absent on the cytoplasmic side, indicating PABPN1 is displaced during or shortly after nuclear pore translocation.","method":"Cryo-immunoelectron microscopy of Chironomus tentans salivary gland Balbiani ring mRNPs at various stages of assembly and transport","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1 — direct structural visualization at multiple stages of mRNA biogenesis and transport","pmids":["12749861"],"is_preprint":false},{"year":2005,"finding":"In Drosophila, PABP2 is required for poly(A) tail synthesis and stimulation of poly(A) polymerase in the nucleus, but also unexpectedly acts in the cytoplasm to shorten poly(A) tails of specific maternal mRNAs (oskar, cyclin B) together with the deadenylase CCR4, thereby controlling Cyclin B protein levels and embryonic development.","method":"Genetic loss-of-function analysis in Drosophila; poly(A) tail length assays; western blotting; genetic interaction with CCR4","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic analysis with multiple molecular readouts (poly(A) tail, protein levels, developmental phenotype)","pmids":["16198293"],"is_preprint":false},{"year":2005,"finding":"Normal PABPN1 is inherently aggregation-prone in HeLa and myogenic C2 cells; inclusion formation depends on domains required for stimulation of poly(A) polymerase, not exclusively on the polyalanine tract. FRAP experiments show that both normal and expanded PABPN1 molecules exchange rapidly in and out of inclusions, arguing they are not irreversibly sequestered.","method":"Exogenous expression of PABPN1 variants in HeLa and C2 cells; FRAP live imaging; inclusion formation assay","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 — live imaging (FRAP) combined with domain-deletion mutagenesis providing mechanistic insight into dynamics of aggregation","pmids":["15811916"],"is_preprint":false},{"year":2005,"finding":"Fission yeast Pab2 (ortholog of PABPN1) is cotranscriptionally recruited to active genes via nascent mRNPs, preceding arrival of typical 3'-processing factors, and also associates with translating polysomes after nuclear export.","method":"Chromatin immunoprecipitation (ChIP) with RNase controls; tandem affinity purification–mass spectrometry; polysome fractionation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP with RNase controls and TAP-MS provide orthogonal evidence for cotranscriptional recruitment and polysome association","pmids":["19336419"],"is_preprint":false},{"year":2006,"finding":"In a Drosophila OPMD model, muscle degeneration requires the RNA-binding domain of PABPN1 and its function in RNA binding, not the polyalanine tract per se, demonstrating that OPMD pathology stems from an intrinsic property of PABPN1 activity, not polyalanine toxicity alone.","method":"Transgenic Drosophila expressing PABPN1 variants (polyalanine deletion, RNA-binding domain mutation); muscle degeneration phenotyping; nuclear inclusion quantification","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic dissection in vivo with domain-specific mutants and clear phenotypic readouts","pmids":["16642034"],"is_preprint":false},{"year":2008,"finding":"Wild-type PABPN1 exerts an anti-apoptotic function by promoting translation of XIAP (X-linked inhibitor of apoptosis protein); PABPN1 knockdown sensitizes cells to apoptosis and mutant PABPN1 partially loses this activity.","method":"PABPN1 overexpression/knockdown in cells and mouse models; staurosporine and Bax-induced apoptosis assays; XIAP protein level measurement by western blot","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional readout with specific downstream target (XIAP), validated in cell and mouse models, single lab","pmids":["18178579"],"is_preprint":false},{"year":2008,"finding":"Deletion of the polyalanine tract in PABPN1 induces aggregates that span both sides of the nuclear membrane, indicating a role for the N-terminal polyalanine tract in nucleocytoplasmic transport of PABPN1.","method":"Expression of polyalanine-deletion PABPN1 constructs in cells; confocal immunofluorescence","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP/localization experiment providing mechanistic insight into nuclear transport role of polyalanine domain","pmids":["18367172"],"is_preprint":false},{"year":2009,"finding":"Expanded PABPN1 preferentially binds heat shock proteins (Hsp70) and type I arginine methyltransferases (PRMT1 and PRMT3) compared to wild-type PABPN1; molecular simulations suggest expansion converts a disordered N-terminal region to a stable helix, promoting this preferential interaction and their sequestration in intranuclear inclusions.","method":"Pull-down assays with recombinant expanded vs. wild-type PABPN1; immunofluorescence in OPMD patient muscle; molecular dynamics simulations","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pull-down plus patient tissue validation; simulation provides structural hypothesis","pmids":["19641605"],"is_preprint":false},{"year":2012,"finding":"Nuclear speckles serve as biogenesis sites for PABPN1 intranuclear inclusions; growing inclusions progressively deplete PABPN1 and poly(A) RNA from speckles, disrupting post-transcriptional processing capacity.","method":"Time-lapse imaging of GFP-PABPN1 in human myoblasts; immunofluorescence in OPMD patient muscle biopsies","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 — live imaging with time-lapse confirms dynamic biogenesis site, validated in patient tissue","pmids":["22249111"],"is_preprint":false},{"year":2013,"finding":"PABPN1 negatively autoregulates its own expression by binding to an adenosine-rich region in its 3' UTR, promoting retention of the 3'-terminal intron and subsequent clearance of intron-retained pre-mRNA by the nuclear exosome (Rrp6-dependent pathway).","method":"Intron retention analysis by RT-PCR; PABPN1 overexpression/knockdown in human cells; nuclear exosome subunit knockdown; RNA immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (splicing assays, knockdown of effectors, RNA binding) defining a novel autoregulatory mechanism","pmids":["25963658"],"is_preprint":false},{"year":2013,"finding":"PABPN1 opposes Nab2 in nuclear poly(A)-binding protein interplay: Pab2 (PABPN1 ortholog in fission yeast) promotes nuclear pre-mRNA decay via Rrp6, while Nab2 competes with Pab2 for polyadenylated transcripts to stabilize them.","method":"Genetic and biochemical analysis in S. pombe; Pab2 and Nab2 deletion strains; mRNA decay assays; competitive binding experiments","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis and competition experiments in fission yeast ortholog system","pmids":["24081329"],"is_preprint":false},{"year":2013,"finding":"A proline-tyrosine nuclear localization signal (PY-NLS) is required for nuclear import of fission yeast Pab2 via karyopherin Kap104, but a functional PY-NLS is not required for nuclear entry of human PABPN1, suggesting alternative or redundant import pathways exist for human PABPN1.","method":"NLS mutagenesis; karyopherin binding assays with recombinant proteins; nuclear localization assays in S. pombe and human cells","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis plus in vitro binding with functional validation in two organisms","pmids":["23279110"],"is_preprint":false},{"year":2014,"finding":"ARIH2 E3-ubiquitin ligase regulates PABPN1 protein accumulation and aggregation; PABPN1 in turn controls ARIH2 mRNA levels via alternative polyadenylation site usage, forming a feed-forward regulatory loop relevant to aging-associated muscle degeneration.","method":"Knockdown/overexpression of ARIH2 and PABPN1 in muscle cells; antisense oligonucleotides masking proximal PAS in ARIH2 3' UTR; protein accumulation and aggregation assays; in vivo mRNA quantification in mouse muscles","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple perturbation methods (KD, ASOs, OE) with molecular and cellular readouts; single lab","pmids":["24486325"],"is_preprint":false},{"year":2015,"finding":"PABPN1 promotes splicing of a subset of introns that are excised after polyadenylation; this splicing-stimulatory function requires PABPN1's RNA-binding activity and, to a lesser extent, its poly(A) polymerase (PAP)-stimulatory function, and operates in the context of the terminal poly(A) tail rather than internal A-tracts.","method":"PABPN1 depletion by RNAi in human cells; splicing assays; recruitment of splicing factors monitored by chromatin immunoprecipitation; domain mutant complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — domain-specific mutant rescue plus mechanistic dissection of splicing factor recruitment; multiple orthogonal assays","pmids":["25896913"],"is_preprint":false},{"year":2017,"finding":"PABPN1 interacts with Matrin 3 (MATR3) in mouse skeletal muscle; both proteins co-regulate alternative polyadenylation, intron retention, and levels of lncRNA Neat1; together they are required for normal paraspeckle function and adenosine-to-inosine RNA editing of Ctn RNA in muscle cells.","method":"Co-immunoprecipitation from mouse skeletal muscle followed by mass spectrometry; knockdown of MATR3 and PABPN1; RNA editing and APA analysis; paraspeckle immunofluorescence in OPMD mouse model","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with MS identification, multiple functional assays, validated in disease model","pmids":["28977530"],"is_preprint":false},{"year":2017,"finding":"CircPABPN1 (hsa_circ_0031288, arising from PABPN1 pre-mRNA) sequesters HuR, preventing HuR from binding to PABPN1 mRNA and thereby suppressing PABPN1 translation; HuR positively regulates PABPN1 translation, and CircPABPN1 negatively regulates it by competitive binding.","method":"HuR-RIP followed by circRNA sequencing; CircPABPN1 overexpression/knockdown; PABPN1 mRNA polysome analysis; RIP of HuR on PABPN1 mRNA","journal":"RNA biology","confidence":"High","confidence_rationale":"Tier 2 — polysome profiling combined with RIP and competition experiments provide mechanistic evidence","pmids":["28080204"],"is_preprint":false},{"year":2018,"finding":"HuR binds to cis-regulatory elements in the Pabpn1 3' UTR and negatively regulates Pabpn1 mRNA stability and hence PABPN1 protein levels specifically in mature skeletal muscle in vitro and in vivo.","method":"RNA immunoprecipitation; HuR overexpression/knockdown in C2C12 myotubes and primary muscle cells; in vivo mouse experiments; mRNA decay assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — RIP plus functional knockdown/overexpression in multiple muscle cell models and in vivo; single lab","pmids":["29939290"],"is_preprint":false},{"year":2019,"finding":"Reduced PABPN1 levels cause elevated SIRT1 deacetylase activity (via alternative polyadenylation-mediated increase in SIRT1 mRNA); SIRT1 inhibition by sirtinol increases PABPN1 levels and reverses muscle wasting, establishing a regulatory loop between PABPN1-mediated APA and SIRT1 deacetylase.","method":"Transcriptomic and proteomic comparison of shPABPN1 vs. control mouse muscles; acetylome profiling; sirtinol pharmacological inhibition; western blotting","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omic approach with pharmacological validation; single lab","pmids":["30739015"],"is_preprint":false},{"year":2019,"finding":"PABPN1 localizes to mitochondria in OPMD patient muscle; both wild-type (10-ala) and expanded (18-ala) PABPN1 accumulate in mitochondria and interact with the TIM23 mitochondrial protein import complex, but the expanded form decreases cell viability and forms aggresomes.","method":"Immunolocalization in OPMD patient muscle; fractionation and co-immunoprecipitation with TIM23 in cell models expressing 10-ala and 18-ala PABPN1; cell viability assays","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP with TIM23 plus localization in patient tissue and cell model; single lab","pmids":["30894671"],"is_preprint":false},{"year":2020,"finding":"PABPN1 is necessary for p63α mRNA translation by modulating binding of translation initiation factors eIF4E and eIF4G to p63α mRNA; PABPN1 also controls alternative polyadenylation of p63 pre-mRNA in coding sequence, and p63α (downstream of p53 family) transcriptionally regulates PABPN1, forming a feedback loop.","method":"PABPN1 knockdown in HaCaT keratinocytes; polysome analysis; eIF4E/eIF4G RNA immunoprecipitation; APA analysis; luciferase reporter for PABPN1 promoter","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal assays (polysome, RIP, APA); single lab","pmids":["32243883"],"is_preprint":false},{"year":2022,"finding":"PABPN1 promotes the formation of nuclear poly(A) domains (NPADs) in mouse oocytes through liquid-liquid phase separation mediated by its N-terminal disordered domain and RNA recognition motif; loss of PABPN1 abolishes NPAD formation, destabilizes oocyte-growth transcripts, and causes female sterility.","method":"Pabpn1 conditional knockout in mouse oocytes; live imaging of NPAD; domain deletion analysis of phase separation; transcript stability assays; fertility phenotyping","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — knockout with multiple molecular and cellular readouts (phase separation, RNA stability, fertility), domain-specific analysis","pmids":["36306357"],"is_preprint":false},{"year":2022,"finding":"Cytoplasmic PABPN1 mediates zygotic genome activation-dependent maternal mRNA clearance (Z-decay) in mouse embryos: it docks on 3'-uridylated transcripts downstream of TUT4/TUT7 and recruits the 3'-5' exoribonuclease DIS3L2, facilitating mRNA decay; Pabpn1 knockout causes developmental arrest at morula stage.","method":"Pabpn1 knockout mice; RNA immunoprecipitation; uridylation assays; DIS3L2 co-immunoprecipitation; transcriptome analysis of maternal mRNA clearance","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — knockout phenotype with molecular pathway placement (TUT4/7→PABPN1→DIS3L2) via co-IP and RNA binding","pmids":["34904664"],"is_preprint":false},{"year":2023,"finding":"The poly(A) tail acts as a splicing enhancer for last introns via PABPN1 in HeLa cells; PABPN1 depletion causes retention of introns with weak 3' splice sites located near the 3' end; PABPN1 recruits RBM26/RBM27 (via interaction with the coiled-coil and RRM domain of RBM27) to promote terminal intron splicing.","method":"PABPN1 knockdown followed by RNA-seq; tethering of PABPN1 to non-polyadenylated transcripts; TurboID proximity labeling-MS for PABPN1 interactome; co-immunoprecipitation of RBM27; conservation analysis in mice","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 — TurboID interactome plus tethering experiment plus domain-specific co-IP providing mechanistic pathway","pmids":["37661812"],"is_preprint":false},{"year":2024,"finding":"SNRPD2 interacts with the glutamic-proline (EP) domain of PABPN1 and disrupts PABPN1 liquid-liquid phase separation (LLPS), reducing suppression of proximal poly(A) sites and causing shortened 3' UTRs (APA shift) that promote colorectal cancer cell proliferation and migration.","method":"APA profiling; LLPS assays; co-immunoprecipitation of SNRPD2 with PABPN1; domain mutagenesis; functional cancer cell assays","journal":"Science China. Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with domain specificity plus LLPS and APA functional readouts; single lab","pmids":["38811444"],"is_preprint":false}],"current_model":"PABPN1 is a nuclear poly(A)-binding protein that binds nascent poly(A) tails cotranscriptionally (associating with RNA Pol II), stimulates poly(A) polymerase, controls poly(A) tail length by forming defined oligomeric particles, suppresses alternative/proximal polyadenylation site usage, promotes splicing of terminal introns by recruiting RBM26/27 and coupling poly(A) tail length to spliceosome recruitment, autoregulates its own expression via intron retention coupled to nuclear exosome decay, undergoes liquid-liquid phase separation to form nuclear poly(A) domains, and in the cytoplasm facilitates maternal mRNA clearance by docking on uridylated transcripts and recruiting DIS3L2; pathogenic polyalanine expansions alter protein conformation, disrupt normal oligomerization, promote amyloid-like fibril formation, sequester RNA-processing factors (hnRNPs, PRMTs, Hsp70) in intranuclear inclusions, and partially compromise anti-apoptotic XIAP translation, collectively causing the muscle-specific disease OPMD."},"narrative":{"teleology":[{"year":1998,"claim":"The genetic cause of OPMD was unknown; identification of short GCG expansions in PABPN1 established that polyalanine expansion from 10 to 12–17 residues is the causative mutation and linked the protein to intranuclear filament inclusions in skeletal muscle.","evidence":"Linkage analysis and mutation screening in 144 OPMD families","pmids":["9462747"],"confidence":"High","gaps":["Mechanism by which expanded polyalanine causes inclusions was unknown","Why pathology is muscle-specific was not addressed","Whether inclusions are causative or correlative was unresolved"]},{"year":2000,"claim":"How PABPN1 sets poly(A) tail length was unclear; EM/SFM revealed that PABPN1 forms discrete oligomeric particles on poly(A) whose maximum size corresponds to the ~250 nt in vivo tail length, providing a molecular ruler model for polyadenylation control.","evidence":"Electron microscopy, scanning force microscopy, gel shift, and filter binding of PABP2·poly(A) complexes","pmids":["10731412"],"confidence":"High","gaps":["How the particle signals termination of polyadenylation was not defined","In vivo validation of the ruler model was lacking"]},{"year":2000,"claim":"The subnuclear localization of PABPN1 was uncharacterized; speckle targeting was shown to depend strictly on poly(A) RNA binding rather than a dedicated localization signal, and expanded PABPN1 was sufficient to drive intranuclear aggregate formation in cell models.","evidence":"Transcription/poly(A) synthesis inhibition, RNA-binding mutants, immunofluorescence in HeLa cells; expression of expanded vs. normal PABPN1 in COS-7 cells","pmids":["10825302","11079546"],"confidence":"High","gaps":["Whether speckle localization is functionally required for PABPN1 activity was unknown","Role of post-translational modifications in localization was not tested"]},{"year":2001,"claim":"Whether PABPN1 oligomerization was required for aggregate-mediated toxicity was untested; deletion of either of two oligomerization domains prevented both nuclear aggregation and cell death, establishing self-oligomerization as essential for OPMD-associated inclusion pathology.","evidence":"Deletion mutagenesis of oligomerization domains in mutant PABPN1; COS-7 expression and cell death assays","pmids":["11689481"],"confidence":"High","gaps":["Structural basis of oligomerization domain function was unresolved","Whether oligomerization is also required for normal poly(A) tail length control was unknown"]},{"year":2003,"claim":"Whether expanded PABPN1 forms canonical amyloid structures and what proteins are sequestered was unknown; biophysical studies showed antiparallel β-sheet amyloid-like fibrils from the expanded N-terminus, and expanded PABPN1 was shown to sequester hnRNP A1/A/B in inclusions in patient muscle.","evidence":"ThT fluorescence, CD spectroscopy, EM of recombinant expanded PABPN1; yeast two-hybrid, GST pull-down, co-IP, and immunofluorescence in patient tissue for hnRNP interactions","pmids":["14627730","12945950"],"confidence":"High","gaps":["Whether sequestration of hnRNPs functionally contributes to disease was not demonstrated","Full inventory of sequestered factors was incomplete"]},{"year":2003,"claim":"Where PABPN1 acts along the gene expression pathway was unclear; cryo-immunoEM showed it associates with RNA Pol II on chromatin, accompanies mRNPs to the nuclear pore, and is stripped during or after translocation, defining its life cycle on the transcript.","evidence":"Cryo-immunoelectron microscopy of Chironomus tentans Balbiani ring mRNPs at sequential stages","pmids":["12749861"],"confidence":"High","gaps":["Mechanism of PABPN1 stripping at the pore was unknown","Whether this cotranscriptional recruitment mechanism is conserved in mammals was not directly shown"]},{"year":2005,"claim":"PABPN1 was considered exclusively a nuclear polyadenylation factor; Drosophila genetics revealed an unexpected cytoplasmic role in shortening poly(A) tails of specific maternal mRNAs (oskar, cyclin B) together with CCR4, controlling protein levels and embryonic development.","evidence":"Genetic loss-of-function in Drosophila; poly(A) tail assays; genetic interaction with CCR4","pmids":["16198293"],"confidence":"High","gaps":["Whether this cytoplasmic deadenylation role is conserved in mammals was unknown at this time","Direct physical interaction with CCR4 was not shown"]},{"year":2006,"claim":"Whether OPMD pathology is driven by polyalanine toxicity or by PABPN1's RNA-processing function was debated; Drosophila studies showed that muscle degeneration requires the RNA-binding domain but not the polyalanine tract, establishing that disease stems from dysregulated RNA processing.","evidence":"Transgenic Drosophila with PABPN1 domain-specific mutants; muscle degeneration and inclusion phenotyping","pmids":["16642034"],"confidence":"High","gaps":["Specific RNA targets whose misprocessing drives muscle degeneration were not identified","Whether the same principle applies in mammalian OPMD models was not confirmed"]},{"year":2009,"claim":"The structural basis for preferential interaction of expanded PABPN1 with chaperones was unknown; pull-down assays and MD simulations revealed that polyalanine expansion converts the disordered N-terminus to a stable helix, enhancing binding to Hsp70, PRMT1, and PRMT3, which are then sequestered in inclusions.","evidence":"Pull-down of expanded vs. WT PABPN1; immunofluorescence in OPMD patient muscle; molecular dynamics simulations","pmids":["19641605"],"confidence":"Medium","gaps":["Whether sequestration of PRMTs has functional consequences for arginine methylation in muscle was not tested","Structural model was based on simulation without experimental structure validation"]},{"year":2013,"claim":"How PABPN1 levels are maintained was unknown; a novel autoregulatory circuit was identified in which PABPN1 promotes retention of its own 3'-terminal intron by binding an A-rich element in the 3' UTR, targeting the unspliced pre-mRNA for Rrp6-dependent nuclear exosome decay.","evidence":"RT-PCR intron retention assays; PABPN1 and Rrp6 knockdown in human cells; RNA immunoprecipitation","pmids":["25963658"],"confidence":"High","gaps":["Whether this autoregulatory mechanism is disrupted in OPMD was not examined","Quantitative contribution of this pathway vs. other regulatory circuits (HuR, circPABPN1) was not determined"]},{"year":2015,"claim":"Whether PABPN1 plays a direct role in splicing was uncertain; depletion experiments revealed that PABPN1 promotes splicing of a subset of post-transcriptionally excised terminal introns, requiring its RNA-binding and PAP-stimulatory activities, linking poly(A) tail addition to splicing commitment.","evidence":"PABPN1 RNAi in human cells; splicing assays; ChIP for splicing factor recruitment; domain mutant complementation","pmids":["25896913"],"confidence":"High","gaps":["Identity of recruited splicing factors was not fully resolved at this stage","Whether intron retention phenotypes in OPMD are direct consequences of this function was not tested"]},{"year":2017,"claim":"PABPN1's interaction partners in muscle and feedback regulation of its own translation were poorly defined; MATR3 was identified as a co-regulator of APA and intron retention in skeletal muscle, while circPABPN1 was shown to compete with PABPN1 mRNA for HuR binding, suppressing PABPN1 translation.","evidence":"Co-IP/MS from mouse muscle (MATR3); HuR-RIP with circRNA sequencing; polysome profiling and competition assays","pmids":["28977530","28080204"],"confidence":"High","gaps":["Whether MATR3-PABPN1 interaction is disrupted in OPMD was not fully resolved","Stoichiometric relationship between circPABPN1 and PABPN1 mRNA in different tissues was unknown"]},{"year":2022,"claim":"PABPN1's roles in oocyte biology and early embryonic development were unknown; conditional knockout revealed that PABPN1 drives NPAD formation through LLPS to stabilize oocyte transcripts (causing sterility when lost), and separately mediates cytoplasmic maternal mRNA clearance by recognizing uridylated tails and recruiting DIS3L2.","evidence":"Pabpn1 cKO in mouse oocytes with LLPS domain analysis and transcript stability assays; Pabpn1 KO embryos with RIP, uridylation assays, and DIS3L2 co-IP","pmids":["36306357","34904664"],"confidence":"High","gaps":["Whether NPAD formation occurs in somatic cells was not determined","How PABPN1 switches from nuclear poly(A)-binding to cytoplasmic uridylated-RNA recognition was mechanistically unresolved"]},{"year":2023,"claim":"The mechanism by which PABPN1 promotes terminal intron splicing was incomplete; TurboID proximity labeling and tethering experiments identified RBM26/RBM27 as direct PABPN1-recruited effectors that couple poly(A) tail presence to spliceosome engagement at last introns with weak 3' splice sites.","evidence":"PABPN1 knockdown + RNA-seq in HeLa; tethering to non-polyadenylated transcripts; TurboID-MS interactome; co-IP of RBM27 with domain mapping","pmids":["37661812"],"confidence":"High","gaps":["Whether RBM26/27 directly contacts spliceosomal components was not shown","Contribution of this pathway to OPMD intron retention phenotypes was not tested"]},{"year":2024,"claim":"How PABPN1 phase separation is regulated by interacting proteins was unknown; SNRPD2 was found to bind the EP domain, disrupt PABPN1 LLPS, and shift polyadenylation toward proximal sites, shortening 3' UTRs and promoting cancer cell proliferation.","evidence":"Co-IP of SNRPD2-PABPN1; LLPS assays with domain mutants; APA profiling; cancer cell functional assays","pmids":["38811444"],"confidence":"Medium","gaps":["Whether SNRPD2-mediated LLPS disruption occurs in normal tissues was not assessed","Structural basis for EP domain interaction with SNRPD2 is lacking","In vivo relevance in tumor models was not demonstrated"]},{"year":null,"claim":"Key open questions include: the structural basis of PABPN1 oligomeric particle assembly and how particle size signals polyadenylation termination; how PABPN1 switches between nuclear poly(A)-binding and cytoplasmic uridylated-RNA recognition; why OPMD pathology is restricted to specific muscles despite ubiquitous PABPN1 expression; and what the full complement of transcripts affected by PABPN1-dependent APA and terminal intron retention is in disease-relevant tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of PABPN1 oligomeric particle exists","Muscle-specific vulnerability in OPMD remains mechanistically unexplained","Genome-wide APA and splicing target maps in OPMD patient muscle are incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[1,2,10,12,21,28,29,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,17,20,21,30]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[28,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3,4,8,16,28]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[2,16,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[9,29]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[8,11]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[1,9,17,21,29,30]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[20,22,25]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[13,27]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,5,7,12]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13]}],"complexes":[],"partners":["MATR3","RBM27","RBM26","DIS3L2","HNRNPA1","SNRPD2","PRMT1","ARIH2"],"other_free_text":[]},"mechanistic_narrative":"PABPN1 is a nuclear poly(A)-binding protein that controls poly(A) tail length, couples polyadenylation to downstream RNA processing events, and undergoes liquid-liquid phase separation to organize nuclear RNA domains. It stimulates poly(A) polymerase and forms oligomeric particles on nascent poly(A) tails whose defined size sets the ~250 nt tail length; it associates cotranscriptionally with RNA polymerase II, accompanies mRNPs to the nuclear pore, suppresses usage of proximal polyadenylation sites, and promotes splicing of terminal introns by recruiting RBM26/RBM27 [PMID:10731412, PMID:12749861, PMID:37661812, PMID:25896913]. PABPN1 autoregulates its own expression through intron retention coupled to nuclear exosome (Rrp6)-dependent decay, forms nuclear poly(A) domains via phase separation in oocytes to stabilize growth-phase transcripts, and in the cytoplasm facilitates maternal mRNA clearance by docking on uridylated transcripts and recruiting the exoribonuclease DIS3L2 [PMID:25963658, PMID:36306357, PMID:34904664]. Short GCG-repeat expansions encoding 12–17 alanines cause oculopharyngeal muscular dystrophy (OPMD); the expanded polyalanine tract adopts an α-helical conformation that promotes amyloid-like fibril formation and intranuclear inclusions that sequester hnRNPs, PRMTs, and Hsp70, with pathology depending on the RNA-binding activity of PABPN1 rather than polyalanine toxicity alone [PMID:9462747, PMID:14627730, PMID:16642034, PMID:19641605]."},"prefetch_data":{"uniprot":{"accession":"Q86U42","full_name":"Polyadenylate-binding protein 2","aliases":["Nuclear poly(A)-binding protein 1","Poly(A)-binding protein II","PABII","Polyadenylate-binding nuclear protein 1"],"length_aa":306,"mass_kda":32.7,"function":"Involved in the 3'-end formation of mRNA precursors (pre-mRNA) by the addition of a poly(A) tail of 200-250 nt to the upstream cleavage product (By similarity). Stimulates poly(A) polymerase (PAPOLA) conferring processivity on the poly(A) tail elongation reaction and also controls the poly(A) tail length (By similarity). Increases the affinity of poly(A) polymerase for RNA (By similarity). Is also present at various stages of mRNA metabolism including nucleocytoplasmic trafficking and nonsense-mediated decay (NMD) of mRNA. Cooperates with SKIP to synergistically activate E-box-mediated transcription through MYOD1 and may regulate the expression of muscle-specific genes (PubMed:11371506). Binds to poly(A) and to poly(G) with high affinity (By similarity). May protect the poly(A) tail from degradation (By similarity). Subunit of the trimeric poly(A) tail exosome targeting (PAXT) complex, a complex that directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor MTREX, which links to RNA-binding protein adapters (PubMed:27871484)","subcellular_location":"Nucleus; Cytoplasm; Nucleus speckle","url":"https://www.uniprot.org/uniprotkb/Q86U42/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PABPN1","classification":"Common Essential","n_dependent_lines":1205,"n_total_lines":1208,"dependency_fraction":0.9975165562913907},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"EMC9","stoichiometry":4.0},{"gene":"RBM33","stoichiometry":4.0},{"gene":"ATG13","stoichiometry":0.2},{"gene":"CPSF6","stoichiometry":0.2},{"gene":"DDX21","stoichiometry":0.2},{"gene":"DHX9","stoichiometry":0.2},{"gene":"ENY2","stoichiometry":0.2},{"gene":"HNRNPL","stoichiometry":0.2},{"gene":"MAP4","stoichiometry":0.2},{"gene":"NCAPH","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PABPN1","total_profiled":1310},"omim":[{"mim_id":"621397","title":"PABPN1-LIKE, CYTOPLASMIC; PABPN1L","url":"https://www.omim.org/entry/621397"},{"mim_id":"620956","title":"ZINC FINGER C3H1 DOMAIN-CONTAINING PROTEIN; ZFC3H1","url":"https://www.omim.org/entry/620956"},{"mim_id":"618640","title":"ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 3; ZC3H3","url":"https://www.omim.org/entry/618640"},{"mim_id":"602279","title":"POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1","url":"https://www.omim.org/entry/602279"},{"mim_id":"164310","title":"OCULOPHARYNGODISTAL MYOPATHY 1; OPDM1","url":"https://www.omim.org/entry/164310"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PABPN1"},"hgnc":{"alias_symbol":["PAB2"],"prev_symbol":["OPMD","PABP2"]},"alphafold":{"accession":"Q86U42","domains":[{"cath_id":"3.30.70.330","chopping":"173-245","consensus_level":"high","plddt":94.6021,"start":173,"end":245}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86U42","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86U42-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86U42-F1-predicted_aligned_error_v6.png","plddt_mean":67.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PABPN1","jax_strain_url":"https://www.jax.org/strain/search?query=PABPN1"},"sequence":{"accession":"Q86U42","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86U42.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86U42/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86U42"}},"corpus_meta":[{"pmid":"28080204","id":"PMC_28080204","title":"Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1.","date":"2017","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/28080204","citation_count":697,"is_preprint":false},{"pmid":"9462747","id":"PMC_9462747","title":"Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9462747","citation_count":625,"is_preprint":false},{"pmid":"15817779","id":"PMC_15817779","title":"The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication.","date":"2005","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15817779","citation_count":170,"is_preprint":false},{"pmid":"12177331","id":"PMC_12177331","title":"Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium.","date":"2002","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12177331","citation_count":141,"is_preprint":false},{"pmid":"11689481","id":"PMC_11689481","title":"Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11689481","citation_count":101,"is_preprint":false},{"pmid":"23601051","id":"PMC_23601051","title":"PABPN1: molecular function and muscle disease.","date":"2013","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/23601051","citation_count":96,"is_preprint":false},{"pmid":"16198293","id":"PMC_16198293","title":"An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila.","date":"2005","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/16198293","citation_count":84,"is_preprint":false},{"pmid":"16642034","id":"PMC_16642034","title":"A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16642034","citation_count":76,"is_preprint":false},{"pmid":"19609631","id":"PMC_19609631","title":"Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons.","date":"2009","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/19609631","citation_count":67,"is_preprint":false},{"pmid":"10731412","id":"PMC_10731412","title":"The nuclear poly(A) binding protein, PABP2, forms an oligomeric particle covering the length of the poly(A) tail.","date":"2000","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10731412","citation_count":66,"is_preprint":false},{"pmid":"12937010","id":"PMC_12937010","title":"Functional cloning and characterization of a multidrug efflux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant.","date":"2003","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/12937010","citation_count":66,"is_preprint":false},{"pmid":"28977530","id":"PMC_28977530","title":"Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28977530","citation_count":62,"is_preprint":false},{"pmid":"25963658","id":"PMC_25963658","title":"Regulated Intron Retention and Nuclear Pre-mRNA Decay Contribute to PABPN1 Autoregulation.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25963658","citation_count":61,"is_preprint":false},{"pmid":"15811916","id":"PMC_15811916","title":"In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.","date":"2005","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15811916","citation_count":59,"is_preprint":false},{"pmid":"11003790","id":"PMC_11003790","title":"Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy.","date":"2000","source":"Muscle & nerve","url":"https://pubmed.ncbi.nlm.nih.gov/11003790","citation_count":58,"is_preprint":false},{"pmid":"15755682","id":"PMC_15755682","title":"PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15755682","citation_count":58,"is_preprint":false},{"pmid":"28361972","id":"PMC_28361972","title":"PABPN1 gene therapy for oculopharyngeal muscular dystrophy.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28361972","citation_count":56,"is_preprint":false},{"pmid":"14645203","id":"PMC_14645203","title":"Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14645203","citation_count":52,"is_preprint":false},{"pmid":"18397876","id":"PMC_18397876","title":"Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18397876","citation_count":51,"is_preprint":false},{"pmid":"28011929","id":"PMC_28011929","title":"Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.","date":"2016","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28011929","citation_count":50,"is_preprint":false},{"pmid":"14627730","id":"PMC_14627730","title":"Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation.","date":"2003","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/14627730","citation_count":49,"is_preprint":false},{"pmid":"31219352","id":"PMC_31219352","title":"Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31219352","citation_count":48,"is_preprint":false},{"pmid":"23793615","id":"PMC_23793615","title":"A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.","date":"2013","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/23793615","citation_count":47,"is_preprint":false},{"pmid":"12945950","id":"PMC_12945950","title":"HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.","date":"2003","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/12945950","citation_count":46,"is_preprint":false},{"pmid":"10825302","id":"PMC_10825302","title":"Localization of poly(A)-binding protein 2 (PABP2) in nuclear speckles is independent of import into the nucleus and requires binding to poly(A) RNA.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10825302","citation_count":43,"is_preprint":false},{"pmid":"16239242","id":"PMC_16239242","title":"Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16239242","citation_count":43,"is_preprint":false},{"pmid":"12749861","id":"PMC_12749861","title":"Nuclear poly(A)-binding protein PABPN1 is associated with RNA polymerase II during transcription and accompanies the released transcript to the nuclear pore.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12749861","citation_count":42,"is_preprint":false},{"pmid":"11087766","id":"PMC_11087766","title":"Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene.","date":"2000","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11087766","citation_count":41,"is_preprint":false},{"pmid":"28575395","id":"PMC_28575395","title":"Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28575395","citation_count":40,"is_preprint":false},{"pmid":"21798095","id":"PMC_21798095","title":"Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients.","date":"2011","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/21798095","citation_count":40,"is_preprint":false},{"pmid":"15645184","id":"PMC_15645184","title":"Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15645184","citation_count":39,"is_preprint":false},{"pmid":"25896913","id":"PMC_25896913","title":"Poly(A) Polymerase and the Nuclear Poly(A) Binding Protein, PABPN1, Coordinate the Splicing and Degradation of a Subset of Human Pre-mRNAs.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25896913","citation_count":39,"is_preprint":false},{"pmid":"18178579","id":"PMC_18178579","title":"Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18178579","citation_count":38,"is_preprint":false},{"pmid":"19641605","id":"PMC_19641605","title":"Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19641605","citation_count":38,"is_preprint":false},{"pmid":"36306357","id":"PMC_36306357","title":"PABPN1 functions as a hub in the assembly of nuclear poly(A) domains that are essential for mouse oocyte development.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36306357","citation_count":38,"is_preprint":false},{"pmid":"15755680","id":"PMC_15755680","title":"Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15755680","citation_count":37,"is_preprint":false},{"pmid":"21204267","id":"PMC_21204267","title":"Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.","date":"2011","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21204267","citation_count":36,"is_preprint":false},{"pmid":"27152426","id":"PMC_27152426","title":"PABPN1-Dependent mRNA Processing Induces Muscle Wasting.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27152426","citation_count":36,"is_preprint":false},{"pmid":"17418585","id":"PMC_17418585","title":"Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.","date":"2007","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/17418585","citation_count":34,"is_preprint":false},{"pmid":"34904664","id":"PMC_34904664","title":"Nuclear poly(A) binding protein 1 (PABPN1) mediates zygotic genome activation-dependent maternal mRNA clearance during mouse early embryonic development.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34904664","citation_count":33,"is_preprint":false},{"pmid":"8029336","id":"PMC_8029336","title":"Molecular characterization of PAB2, a member of the multigene family coding for poly(A)-binding proteins in Arabidopsis thaliana.","date":"1993","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8029336","citation_count":33,"is_preprint":false},{"pmid":"24083404","id":"PMC_24083404","title":"Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle.","date":"2013","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/24083404","citation_count":33,"is_preprint":false},{"pmid":"18367172","id":"PMC_18367172","title":"PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18367172","citation_count":33,"is_preprint":false},{"pmid":"35334101","id":"PMC_35334101","title":"Exosome-Mediated Transfer of miR-1323 from Cancer-Associated Fibroblasts Confers Radioresistance of C33A Cells by Targeting PABPN1 and Activating Wnt/β-Catenin Signaling Pathway in Cervical Cancer.","date":"2022","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/35334101","citation_count":32,"is_preprint":false},{"pmid":"11079546","id":"PMC_11079546","title":"PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy.","date":"2000","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11079546","citation_count":32,"is_preprint":false},{"pmid":"16648376","id":"PMC_16648376","title":"Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.","date":"2006","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16648376","citation_count":32,"is_preprint":false},{"pmid":"31066242","id":"PMC_31066242","title":"Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).","date":"2019","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/31066242","citation_count":31,"is_preprint":false},{"pmid":"11890856","id":"PMC_11890856","title":"Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy.","date":"2002","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11890856","citation_count":30,"is_preprint":false},{"pmid":"21854744","id":"PMC_21854744","title":"Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21854744","citation_count":30,"is_preprint":false},{"pmid":"19336419","id":"PMC_19336419","title":"Cotranscriptional recruitment of the nuclear poly(A)-binding protein Pab2 to nascent transcripts and association with translating mRNPs.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19336419","citation_count":28,"is_preprint":false},{"pmid":"12445646","id":"PMC_12445646","title":"Characterization of outer membrane efflux proteins OpmE, OpmD and OpmB of Pseudomonas aeruginosa: molecular cloning and development of specific antisera.","date":"2002","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/12445646","citation_count":28,"is_preprint":false},{"pmid":"10734263","id":"PMC_10734263","title":"Oculopharyngeal muscular dystrophy in a Japanese family with a short GCG expansion (GCG)(11) in PABP2 gene.","date":"2000","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/10734263","citation_count":27,"is_preprint":false},{"pmid":"24486325","id":"PMC_24486325","title":"A novel feed-forward loop between ARIH2 E3-ligase and PABPN1 regulates aging-associated muscle degeneration.","date":"2014","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24486325","citation_count":26,"is_preprint":false},{"pmid":"24081329","id":"PMC_24081329","title":"Poly(A) tail-mediated gene regulation by opposing roles of Nab2 and Pab2 nuclear poly(A)-binding proteins in pre-mRNA decay.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24081329","citation_count":25,"is_preprint":false},{"pmid":"12673802","id":"PMC_12673802","title":"Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12673802","citation_count":25,"is_preprint":false},{"pmid":"30040867","id":"PMC_30040867","title":"Comparative proteomics of the two T. brucei PABPs suggests that PABP2 controls bulk mRNA.","date":"2018","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30040867","citation_count":25,"is_preprint":false},{"pmid":"10508991","id":"PMC_10508991","title":"Unique PABP2 mutations in \"Cajuns\" suggest multiple founders of oculopharyngeal muscular dystrophy in populations with French ancestry.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10508991","citation_count":25,"is_preprint":false},{"pmid":"26130692","id":"PMC_26130692","title":"PABPN1 suppresses TDP-43 toxicity in ALS disease models.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26130692","citation_count":24,"is_preprint":false},{"pmid":"10849337","id":"PMC_10849337","title":"Arabidopsis thaliana poly (A) binding protein 2 (PAB2) functions in yeast translational and mRNA decay processes.","date":"2000","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10849337","citation_count":22,"is_preprint":false},{"pmid":"37661812","id":"PMC_37661812","title":"The polyA tail facilitates splicing of last introns with weak 3' splice sites via PABPN1.","date":"2023","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/37661812","citation_count":22,"is_preprint":false},{"pmid":"23279110","id":"PMC_23279110","title":"A proline-tyrosine nuclear localization signal (PY-NLS) is required for the nuclear import of fission yeast PAB2, but not of human PABPN1.","date":"2013","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/23279110","citation_count":22,"is_preprint":false},{"pmid":"34453920","id":"PMC_34453920","title":"Propofol suppresses colorectal cancer development by the circ-PABPN1/miR-638/SRSF1 axis.","date":"2021","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34453920","citation_count":21,"is_preprint":false},{"pmid":"23300856","id":"PMC_23300856","title":"Depletion of nuclear poly(A) binding protein PABPN1 produces a compensatory response by cytoplasmic PABP4 and PABP5 in cultured human cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23300856","citation_count":21,"is_preprint":false},{"pmid":"10849338","id":"PMC_10849338","title":"Conserved expression of Arabidopsis thaliana poly (A) binding protein 2 (PAB2) in distinct vegetative and reproductive tissues.","date":"2000","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10849338","citation_count":21,"is_preprint":false},{"pmid":"21818414","id":"PMC_21818414","title":"Reversible aggregation of PABPN1 pre-inclusion structures.","date":"2011","source":"Nucleus (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21818414","citation_count":19,"is_preprint":false},{"pmid":"18205394","id":"PMC_18205394","title":"Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18205394","citation_count":18,"is_preprint":false},{"pmid":"29939290","id":"PMC_29939290","title":"Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29939290","citation_count":17,"is_preprint":false},{"pmid":"27858728","id":"PMC_27858728","title":"PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.","date":"2015","source":"Journal of neuromuscular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27858728","citation_count":17,"is_preprint":false},{"pmid":"18255312","id":"PMC_18255312","title":"Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions.","date":"2007","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18255312","citation_count":17,"is_preprint":false},{"pmid":"22641371","id":"PMC_22641371","title":"PABPN1 shuts down alternative poly(A) sites.","date":"2012","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22641371","citation_count":17,"is_preprint":false},{"pmid":"33682567","id":"PMC_33682567","title":"Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?","date":"2021","source":"Expert review of molecular diagnostics","url":"https://pubmed.ncbi.nlm.nih.gov/33682567","citation_count":16,"is_preprint":false},{"pmid":"22249111","id":"PMC_22249111","title":"Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/22249111","citation_count":16,"is_preprint":false},{"pmid":"16860991","id":"PMC_16860991","title":"The dynamism of PABPN1 nuclear inclusions during the cell cycle.","date":"2006","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/16860991","citation_count":15,"is_preprint":false},{"pmid":"28649424","id":"PMC_28649424","title":"An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites.","date":"2017","source":"NPJ aging and mechanisms of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28649424","citation_count":15,"is_preprint":false},{"pmid":"17229142","id":"PMC_17229142","title":"Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1.","date":"2007","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17229142","citation_count":15,"is_preprint":false},{"pmid":"21415013","id":"PMC_21415013","title":"The type II poly(A)-binding protein PABP-2 genetically interacts with the let-7 miRNA and elicits heterochronic phenotypes in Caenorhabditis elegans.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21415013","citation_count":15,"is_preprint":false},{"pmid":"15694141","id":"PMC_15694141","title":"(GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families.","date":"2005","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/15694141","citation_count":14,"is_preprint":false},{"pmid":"9084936","id":"PMC_9084936","title":"Oculopharyngeal muscular dystrophy (OPMD)--report and genetic studies of an Australian kindred.","date":"1997","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9084936","citation_count":14,"is_preprint":false},{"pmid":"38811444","id":"PMC_38811444","title":"Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.","date":"2024","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38811444","citation_count":13,"is_preprint":false},{"pmid":"30739015","id":"PMC_30739015","title":"Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/30739015","citation_count":13,"is_preprint":false},{"pmid":"35894779","id":"PMC_35894779","title":"Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35894779","citation_count":13,"is_preprint":false},{"pmid":"22570486","id":"PMC_22570486","title":"Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22570486","citation_count":13,"is_preprint":false},{"pmid":"36879298","id":"PMC_36879298","title":"PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36879298","citation_count":13,"is_preprint":false},{"pmid":"17550990","id":"PMC_17550990","title":"Multiple mitochondrial DNA deletions in monozygotic twins with OPMD.","date":"2007","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17550990","citation_count":12,"is_preprint":false},{"pmid":"29088723","id":"PMC_29088723","title":"Dysfunctional transcripts are formed by alternative polyadenylation in OPMD.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088723","citation_count":12,"is_preprint":false},{"pmid":"26527730","id":"PMC_26527730","title":"Automated design of hammerhead ribozymes and validation by targeting the PABPN1 gene transcript.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26527730","citation_count":12,"is_preprint":false},{"pmid":"20227501","id":"PMC_20227501","title":"Cross-talk between canonical Wnt signaling and the sirtuin-FoxO longevity pathway to protect against muscular pathology induced by mutant PABPN1 expression in C. elegans.","date":"2010","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/20227501","citation_count":12,"is_preprint":false},{"pmid":"22817818","id":"PMC_22817818","title":"Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.","date":"2012","source":"Journal of the Formosan Medical Association = Taiwan yi zhi","url":"https://pubmed.ncbi.nlm.nih.gov/22817818","citation_count":11,"is_preprint":false},{"pmid":"32243883","id":"PMC_32243883","title":"PABPN1, a Target of p63, Modulates Keratinocyte Differentiation through Regulation of p63α mRNA Translation.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32243883","citation_count":11,"is_preprint":false},{"pmid":"36197469","id":"PMC_36197469","title":"Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.","date":"2022","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/36197469","citation_count":10,"is_preprint":false},{"pmid":"33533011","id":"PMC_33533011","title":"Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.","date":"2021","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/33533011","citation_count":10,"is_preprint":false},{"pmid":"36657275","id":"PMC_36657275","title":"MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.","date":"2023","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/36657275","citation_count":10,"is_preprint":false},{"pmid":"30894671","id":"PMC_30894671","title":"Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.","date":"2019","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30894671","citation_count":9,"is_preprint":false},{"pmid":"10534404","id":"PMC_10534404","title":"The promoter of the Poly(A) binding protein 2 (Pabp2) retroposon is derived from the 5'-untranslated region of the Pabp1 progenitor gene.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10534404","citation_count":9,"is_preprint":false},{"pmid":"34225694","id":"PMC_34225694","title":"A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.","date":"2021","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34225694","citation_count":9,"is_preprint":false},{"pmid":"38213032","id":"PMC_38213032","title":"PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.","date":"2024","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/38213032","citation_count":9,"is_preprint":false},{"pmid":"15725589","id":"PMC_15725589","title":"Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.","date":"2005","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/15725589","citation_count":9,"is_preprint":false},{"pmid":"38244911","id":"PMC_38244911","title":"Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38244911","citation_count":8,"is_preprint":false},{"pmid":"33077830","id":"PMC_33077830","title":"Cytoskeletal disorganization underlies PABPN1-mediated myogenic disability.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33077830","citation_count":8,"is_preprint":false},{"pmid":"27980005","id":"PMC_27980005","title":"Characterization of PABPN1 expansion mutations in a large cohort of Mexican patients with oculopharyngeal muscular dystrophy (OPMD).","date":"2016","source":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","url":"https://pubmed.ncbi.nlm.nih.gov/27980005","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47833,"output_tokens":7549,"usd":0.128367},"stage2":{"model":"claude-opus-4-6","input_tokens":11295,"output_tokens":4337,"usd":0.24735},"total_usd":0.375717,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Short GCG expansions in the PABPN1 gene expand the N-terminal polyalanine tract from 10 to 12–17 alanines, causing oculopharyngeal muscular dystrophy (OPMD) and leading to accumulation of nuclear filament inclusions in skeletal muscle fibres.\",\n      \"method\": \"Genetic linkage and mutation analysis in 144 OPMD families\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational mutation discovery, replicated across many subsequent studies\",\n      \"pmids\": [\"9462747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PABPN1 (PABP2) bound to poly(A) RNA forms both linear filaments and discrete-sized, compact oligomeric particles (~21 nm diameter) whose maximum size corresponds to poly(A) tails of 200–300 nt, consistent with in vivo poly(A) tail length; filament-to-particle equilibrium is sensitive to ionic strength.\",\n      \"method\": \"Electron microscopy and scanning force microscopy of PABP2·poly(A) complexes; gel mobility shift and nitrocellulose filter binding assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural characterization by multiple orthogonal imaging methods with functional correlation\",\n      \"pmids\": [\"10731412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PABPN1 localizes to nuclear speckles strictly as a consequence of its binding to poly(A) RNA; this localization is independent of nuclear import per se but requires functional poly(A) binding (mutants with reduced poly(A) affinity fail to localize to speckles).\",\n      \"method\": \"Inhibition of transcription/poly(A) synthesis at end of mitosis; PABPN1 mutant expression in HeLa cells; immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple perturbations (transcription inhibition, poly(A) synthesis block, RNA-binding mutants) with consistent localization readout\",\n      \"pmids\": [\"10825302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Expanded PABPN1 (mutant PABP2) protein accumulates exclusively in intranuclear aggregates in muscle fibers of OPMD patients, not in normal controls, suggesting molecular modification (e.g., arginine dimethylation at residues 271–291 may differ in mutant protein).\",\n      \"method\": \"Immunofluorescence with peptide antiserum recognizing residues 271–291 on patient muscle biopsies\",\n      \"journal\": \"Muscle & nerve\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization in patient tissue with functional implication, single lab\",\n      \"pmids\": [\"11003790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Expression of mutated PABP2 (expanded polyalanine) cDNA in COS-7 cells is sufficient to induce its accumulation as intranuclear inclusions, demonstrating that the polyalanine expansion directly drives nuclear aggregate formation.\",\n      \"method\": \"Transfection of normal vs. expanded PABP2 constructs in COS-7 cells; immunofluorescence\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct cell model experiment establishing sufficiency of expanded polyalanine for inclusion formation, replicated by multiple subsequent studies\",\n      \"pmids\": [\"11079546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PABPN1 oligomerization is mediated by two oligomerization domains (ODs); inactivating either OD by 6–8 amino acid deletions prevents mutant PABPN1-induced nuclear protein aggregation and significantly reduces associated cell death in COS-7 cells.\",\n      \"method\": \"Deletion mutagenesis of ODs in mutant PABPN1; expression in COS-7 cells; immunofluorescence; cell death assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis-based dissection of oligomerization domains with direct cellular phenotypic readout\",\n      \"pmids\": [\"11689481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PABPN1 interacts with hnRNP A1 and hnRNP A/B; when co-expressed with expanded PABPN1 in COS-7 cells, these proteins co-localize with mutant PABPN1 in insoluble intranuclear aggregates, and hnRNP A1 is sequestered in OPMD nuclear inclusions in patient muscle.\",\n      \"method\": \"Yeast two-hybrid screen; GST pull-down; co-immunoprecipitation; co-localization in OPMD patient muscle and cellular model\",\n      \"journal\": \"The Canadian journal of neurological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding confirmed by multiple methods (Y2H, pull-down, co-IP) and verified in patient tissue\",\n      \"pmids\": [\"12945950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Polyalanine-expanded PABPN1 N-terminal fragments form amyloid-like fibrils with antiparallel beta-sheet structure; expansion of poly-L-alanine to maximal OPMD length increases alpha-helical content and fibril formation that can be seeded.\",\n      \"method\": \"Recombinant protein production; ThT fluorescence; CD spectroscopy; electron microscopy; seeding experiments\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with structural characterization; biophysical properties linked to disease-causing expansions\",\n      \"pmids\": [\"14627730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PABPN1 is associated with RNA polymerase II along the chromatin axis and accompanies the released mRNA ribonucleoprotein (mRNP) to the nuclear pore, but is largely absent on the cytoplasmic side, indicating PABPN1 is displaced during or shortly after nuclear pore translocation.\",\n      \"method\": \"Cryo-immunoelectron microscopy of Chironomus tentans salivary gland Balbiani ring mRNPs at various stages of assembly and transport\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural visualization at multiple stages of mRNA biogenesis and transport\",\n      \"pmids\": [\"12749861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In Drosophila, PABP2 is required for poly(A) tail synthesis and stimulation of poly(A) polymerase in the nucleus, but also unexpectedly acts in the cytoplasm to shorten poly(A) tails of specific maternal mRNAs (oskar, cyclin B) together with the deadenylase CCR4, thereby controlling Cyclin B protein levels and embryonic development.\",\n      \"method\": \"Genetic loss-of-function analysis in Drosophila; poly(A) tail length assays; western blotting; genetic interaction with CCR4\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic analysis with multiple molecular readouts (poly(A) tail, protein levels, developmental phenotype)\",\n      \"pmids\": [\"16198293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Normal PABPN1 is inherently aggregation-prone in HeLa and myogenic C2 cells; inclusion formation depends on domains required for stimulation of poly(A) polymerase, not exclusively on the polyalanine tract. FRAP experiments show that both normal and expanded PABPN1 molecules exchange rapidly in and out of inclusions, arguing they are not irreversibly sequestered.\",\n      \"method\": \"Exogenous expression of PABPN1 variants in HeLa and C2 cells; FRAP live imaging; inclusion formation assay\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — live imaging (FRAP) combined with domain-deletion mutagenesis providing mechanistic insight into dynamics of aggregation\",\n      \"pmids\": [\"15811916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Fission yeast Pab2 (ortholog of PABPN1) is cotranscriptionally recruited to active genes via nascent mRNPs, preceding arrival of typical 3'-processing factors, and also associates with translating polysomes after nuclear export.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) with RNase controls; tandem affinity purification–mass spectrometry; polysome fractionation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP with RNase controls and TAP-MS provide orthogonal evidence for cotranscriptional recruitment and polysome association\",\n      \"pmids\": [\"19336419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In a Drosophila OPMD model, muscle degeneration requires the RNA-binding domain of PABPN1 and its function in RNA binding, not the polyalanine tract per se, demonstrating that OPMD pathology stems from an intrinsic property of PABPN1 activity, not polyalanine toxicity alone.\",\n      \"method\": \"Transgenic Drosophila expressing PABPN1 variants (polyalanine deletion, RNA-binding domain mutation); muscle degeneration phenotyping; nuclear inclusion quantification\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic dissection in vivo with domain-specific mutants and clear phenotypic readouts\",\n      \"pmids\": [\"16642034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Wild-type PABPN1 exerts an anti-apoptotic function by promoting translation of XIAP (X-linked inhibitor of apoptosis protein); PABPN1 knockdown sensitizes cells to apoptosis and mutant PABPN1 partially loses this activity.\",\n      \"method\": \"PABPN1 overexpression/knockdown in cells and mouse models; staurosporine and Bax-induced apoptosis assays; XIAP protein level measurement by western blot\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional readout with specific downstream target (XIAP), validated in cell and mouse models, single lab\",\n      \"pmids\": [\"18178579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Deletion of the polyalanine tract in PABPN1 induces aggregates that span both sides of the nuclear membrane, indicating a role for the N-terminal polyalanine tract in nucleocytoplasmic transport of PABPN1.\",\n      \"method\": \"Expression of polyalanine-deletion PABPN1 constructs in cells; confocal immunofluorescence\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/localization experiment providing mechanistic insight into nuclear transport role of polyalanine domain\",\n      \"pmids\": [\"18367172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Expanded PABPN1 preferentially binds heat shock proteins (Hsp70) and type I arginine methyltransferases (PRMT1 and PRMT3) compared to wild-type PABPN1; molecular simulations suggest expansion converts a disordered N-terminal region to a stable helix, promoting this preferential interaction and their sequestration in intranuclear inclusions.\",\n      \"method\": \"Pull-down assays with recombinant expanded vs. wild-type PABPN1; immunofluorescence in OPMD patient muscle; molecular dynamics simulations\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pull-down plus patient tissue validation; simulation provides structural hypothesis\",\n      \"pmids\": [\"19641605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Nuclear speckles serve as biogenesis sites for PABPN1 intranuclear inclusions; growing inclusions progressively deplete PABPN1 and poly(A) RNA from speckles, disrupting post-transcriptional processing capacity.\",\n      \"method\": \"Time-lapse imaging of GFP-PABPN1 in human myoblasts; immunofluorescence in OPMD patient muscle biopsies\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live imaging with time-lapse confirms dynamic biogenesis site, validated in patient tissue\",\n      \"pmids\": [\"22249111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PABPN1 negatively autoregulates its own expression by binding to an adenosine-rich region in its 3' UTR, promoting retention of the 3'-terminal intron and subsequent clearance of intron-retained pre-mRNA by the nuclear exosome (Rrp6-dependent pathway).\",\n      \"method\": \"Intron retention analysis by RT-PCR; PABPN1 overexpression/knockdown in human cells; nuclear exosome subunit knockdown; RNA immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (splicing assays, knockdown of effectors, RNA binding) defining a novel autoregulatory mechanism\",\n      \"pmids\": [\"25963658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PABPN1 opposes Nab2 in nuclear poly(A)-binding protein interplay: Pab2 (PABPN1 ortholog in fission yeast) promotes nuclear pre-mRNA decay via Rrp6, while Nab2 competes with Pab2 for polyadenylated transcripts to stabilize them.\",\n      \"method\": \"Genetic and biochemical analysis in S. pombe; Pab2 and Nab2 deletion strains; mRNA decay assays; competitive binding experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis and competition experiments in fission yeast ortholog system\",\n      \"pmids\": [\"24081329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A proline-tyrosine nuclear localization signal (PY-NLS) is required for nuclear import of fission yeast Pab2 via karyopherin Kap104, but a functional PY-NLS is not required for nuclear entry of human PABPN1, suggesting alternative or redundant import pathways exist for human PABPN1.\",\n      \"method\": \"NLS mutagenesis; karyopherin binding assays with recombinant proteins; nuclear localization assays in S. pombe and human cells\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus in vitro binding with functional validation in two organisms\",\n      \"pmids\": [\"23279110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARIH2 E3-ubiquitin ligase regulates PABPN1 protein accumulation and aggregation; PABPN1 in turn controls ARIH2 mRNA levels via alternative polyadenylation site usage, forming a feed-forward regulatory loop relevant to aging-associated muscle degeneration.\",\n      \"method\": \"Knockdown/overexpression of ARIH2 and PABPN1 in muscle cells; antisense oligonucleotides masking proximal PAS in ARIH2 3' UTR; protein accumulation and aggregation assays; in vivo mRNA quantification in mouse muscles\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple perturbation methods (KD, ASOs, OE) with molecular and cellular readouts; single lab\",\n      \"pmids\": [\"24486325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PABPN1 promotes splicing of a subset of introns that are excised after polyadenylation; this splicing-stimulatory function requires PABPN1's RNA-binding activity and, to a lesser extent, its poly(A) polymerase (PAP)-stimulatory function, and operates in the context of the terminal poly(A) tail rather than internal A-tracts.\",\n      \"method\": \"PABPN1 depletion by RNAi in human cells; splicing assays; recruitment of splicing factors monitored by chromatin immunoprecipitation; domain mutant complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific mutant rescue plus mechanistic dissection of splicing factor recruitment; multiple orthogonal assays\",\n      \"pmids\": [\"25896913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PABPN1 interacts with Matrin 3 (MATR3) in mouse skeletal muscle; both proteins co-regulate alternative polyadenylation, intron retention, and levels of lncRNA Neat1; together they are required for normal paraspeckle function and adenosine-to-inosine RNA editing of Ctn RNA in muscle cells.\",\n      \"method\": \"Co-immunoprecipitation from mouse skeletal muscle followed by mass spectrometry; knockdown of MATR3 and PABPN1; RNA editing and APA analysis; paraspeckle immunofluorescence in OPMD mouse model\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with MS identification, multiple functional assays, validated in disease model\",\n      \"pmids\": [\"28977530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CircPABPN1 (hsa_circ_0031288, arising from PABPN1 pre-mRNA) sequesters HuR, preventing HuR from binding to PABPN1 mRNA and thereby suppressing PABPN1 translation; HuR positively regulates PABPN1 translation, and CircPABPN1 negatively regulates it by competitive binding.\",\n      \"method\": \"HuR-RIP followed by circRNA sequencing; CircPABPN1 overexpression/knockdown; PABPN1 mRNA polysome analysis; RIP of HuR on PABPN1 mRNA\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — polysome profiling combined with RIP and competition experiments provide mechanistic evidence\",\n      \"pmids\": [\"28080204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HuR binds to cis-regulatory elements in the Pabpn1 3' UTR and negatively regulates Pabpn1 mRNA stability and hence PABPN1 protein levels specifically in mature skeletal muscle in vitro and in vivo.\",\n      \"method\": \"RNA immunoprecipitation; HuR overexpression/knockdown in C2C12 myotubes and primary muscle cells; in vivo mouse experiments; mRNA decay assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP plus functional knockdown/overexpression in multiple muscle cell models and in vivo; single lab\",\n      \"pmids\": [\"29939290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Reduced PABPN1 levels cause elevated SIRT1 deacetylase activity (via alternative polyadenylation-mediated increase in SIRT1 mRNA); SIRT1 inhibition by sirtinol increases PABPN1 levels and reverses muscle wasting, establishing a regulatory loop between PABPN1-mediated APA and SIRT1 deacetylase.\",\n      \"method\": \"Transcriptomic and proteomic comparison of shPABPN1 vs. control mouse muscles; acetylome profiling; sirtinol pharmacological inhibition; western blotting\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic approach with pharmacological validation; single lab\",\n      \"pmids\": [\"30739015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PABPN1 localizes to mitochondria in OPMD patient muscle; both wild-type (10-ala) and expanded (18-ala) PABPN1 accumulate in mitochondria and interact with the TIM23 mitochondrial protein import complex, but the expanded form decreases cell viability and forms aggresomes.\",\n      \"method\": \"Immunolocalization in OPMD patient muscle; fractionation and co-immunoprecipitation with TIM23 in cell models expressing 10-ala and 18-ala PABPN1; cell viability assays\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP with TIM23 plus localization in patient tissue and cell model; single lab\",\n      \"pmids\": [\"30894671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PABPN1 is necessary for p63α mRNA translation by modulating binding of translation initiation factors eIF4E and eIF4G to p63α mRNA; PABPN1 also controls alternative polyadenylation of p63 pre-mRNA in coding sequence, and p63α (downstream of p53 family) transcriptionally regulates PABPN1, forming a feedback loop.\",\n      \"method\": \"PABPN1 knockdown in HaCaT keratinocytes; polysome analysis; eIF4E/eIF4G RNA immunoprecipitation; APA analysis; luciferase reporter for PABPN1 promoter\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays (polysome, RIP, APA); single lab\",\n      \"pmids\": [\"32243883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PABPN1 promotes the formation of nuclear poly(A) domains (NPADs) in mouse oocytes through liquid-liquid phase separation mediated by its N-terminal disordered domain and RNA recognition motif; loss of PABPN1 abolishes NPAD formation, destabilizes oocyte-growth transcripts, and causes female sterility.\",\n      \"method\": \"Pabpn1 conditional knockout in mouse oocytes; live imaging of NPAD; domain deletion analysis of phase separation; transcript stability assays; fertility phenotyping\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with multiple molecular and cellular readouts (phase separation, RNA stability, fertility), domain-specific analysis\",\n      \"pmids\": [\"36306357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cytoplasmic PABPN1 mediates zygotic genome activation-dependent maternal mRNA clearance (Z-decay) in mouse embryos: it docks on 3'-uridylated transcripts downstream of TUT4/TUT7 and recruits the 3'-5' exoribonuclease DIS3L2, facilitating mRNA decay; Pabpn1 knockout causes developmental arrest at morula stage.\",\n      \"method\": \"Pabpn1 knockout mice; RNA immunoprecipitation; uridylation assays; DIS3L2 co-immunoprecipitation; transcriptome analysis of maternal mRNA clearance\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout phenotype with molecular pathway placement (TUT4/7→PABPN1→DIS3L2) via co-IP and RNA binding\",\n      \"pmids\": [\"34904664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The poly(A) tail acts as a splicing enhancer for last introns via PABPN1 in HeLa cells; PABPN1 depletion causes retention of introns with weak 3' splice sites located near the 3' end; PABPN1 recruits RBM26/RBM27 (via interaction with the coiled-coil and RRM domain of RBM27) to promote terminal intron splicing.\",\n      \"method\": \"PABPN1 knockdown followed by RNA-seq; tethering of PABPN1 to non-polyadenylated transcripts; TurboID proximity labeling-MS for PABPN1 interactome; co-immunoprecipitation of RBM27; conservation analysis in mice\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — TurboID interactome plus tethering experiment plus domain-specific co-IP providing mechanistic pathway\",\n      \"pmids\": [\"37661812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SNRPD2 interacts with the glutamic-proline (EP) domain of PABPN1 and disrupts PABPN1 liquid-liquid phase separation (LLPS), reducing suppression of proximal poly(A) sites and causing shortened 3' UTRs (APA shift) that promote colorectal cancer cell proliferation and migration.\",\n      \"method\": \"APA profiling; LLPS assays; co-immunoprecipitation of SNRPD2 with PABPN1; domain mutagenesis; functional cancer cell assays\",\n      \"journal\": \"Science China. Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with domain specificity plus LLPS and APA functional readouts; single lab\",\n      \"pmids\": [\"38811444\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PABPN1 is a nuclear poly(A)-binding protein that binds nascent poly(A) tails cotranscriptionally (associating with RNA Pol II), stimulates poly(A) polymerase, controls poly(A) tail length by forming defined oligomeric particles, suppresses alternative/proximal polyadenylation site usage, promotes splicing of terminal introns by recruiting RBM26/27 and coupling poly(A) tail length to spliceosome recruitment, autoregulates its own expression via intron retention coupled to nuclear exosome decay, undergoes liquid-liquid phase separation to form nuclear poly(A) domains, and in the cytoplasm facilitates maternal mRNA clearance by docking on uridylated transcripts and recruiting DIS3L2; pathogenic polyalanine expansions alter protein conformation, disrupt normal oligomerization, promote amyloid-like fibril formation, sequester RNA-processing factors (hnRNPs, PRMTs, Hsp70) in intranuclear inclusions, and partially compromise anti-apoptotic XIAP translation, collectively causing the muscle-specific disease OPMD.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PABPN1 is a nuclear poly(A)-binding protein that controls poly(A) tail length, couples polyadenylation to downstream RNA processing events, and undergoes liquid-liquid phase separation to organize nuclear RNA domains. It stimulates poly(A) polymerase and forms oligomeric particles on nascent poly(A) tails whose defined size sets the ~250 nt tail length; it associates cotranscriptionally with RNA polymerase II, accompanies mRNPs to the nuclear pore, suppresses usage of proximal polyadenylation sites, and promotes splicing of terminal introns by recruiting RBM26/RBM27 [PMID:10731412, PMID:12749861, PMID:37661812, PMID:25896913]. PABPN1 autoregulates its own expression through intron retention coupled to nuclear exosome (Rrp6)-dependent decay, forms nuclear poly(A) domains via phase separation in oocytes to stabilize growth-phase transcripts, and in the cytoplasm facilitates maternal mRNA clearance by docking on uridylated transcripts and recruiting the exoribonuclease DIS3L2 [PMID:25963658, PMID:36306357, PMID:34904664]. Short GCG-repeat expansions encoding 12–17 alanines cause oculopharyngeal muscular dystrophy (OPMD); the expanded polyalanine tract adopts an α-helical conformation that promotes amyloid-like fibril formation and intranuclear inclusions that sequester hnRNPs, PRMTs, and Hsp70, with pathology depending on the RNA-binding activity of PABPN1 rather than polyalanine toxicity alone [PMID:9462747, PMID:14627730, PMID:16642034, PMID:19641605].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The genetic cause of OPMD was unknown; identification of short GCG expansions in PABPN1 established that polyalanine expansion from 10 to 12–17 residues is the causative mutation and linked the protein to intranuclear filament inclusions in skeletal muscle.\",\n      \"evidence\": \"Linkage analysis and mutation screening in 144 OPMD families\",\n      \"pmids\": [\"9462747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which expanded polyalanine causes inclusions was unknown\", \"Why pathology is muscle-specific was not addressed\", \"Whether inclusions are causative or correlative was unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"How PABPN1 sets poly(A) tail length was unclear; EM/SFM revealed that PABPN1 forms discrete oligomeric particles on poly(A) whose maximum size corresponds to the ~250 nt in vivo tail length, providing a molecular ruler model for polyadenylation control.\",\n      \"evidence\": \"Electron microscopy, scanning force microscopy, gel shift, and filter binding of PABP2·poly(A) complexes\",\n      \"pmids\": [\"10731412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the particle signals termination of polyadenylation was not defined\", \"In vivo validation of the ruler model was lacking\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The subnuclear localization of PABPN1 was uncharacterized; speckle targeting was shown to depend strictly on poly(A) RNA binding rather than a dedicated localization signal, and expanded PABPN1 was sufficient to drive intranuclear aggregate formation in cell models.\",\n      \"evidence\": \"Transcription/poly(A) synthesis inhibition, RNA-binding mutants, immunofluorescence in HeLa cells; expression of expanded vs. normal PABPN1 in COS-7 cells\",\n      \"pmids\": [\"10825302\", \"11079546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether speckle localization is functionally required for PABPN1 activity was unknown\", \"Role of post-translational modifications in localization was not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Whether PABPN1 oligomerization was required for aggregate-mediated toxicity was untested; deletion of either of two oligomerization domains prevented both nuclear aggregation and cell death, establishing self-oligomerization as essential for OPMD-associated inclusion pathology.\",\n      \"evidence\": \"Deletion mutagenesis of oligomerization domains in mutant PABPN1; COS-7 expression and cell death assays\",\n      \"pmids\": [\"11689481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of oligomerization domain function was unresolved\", \"Whether oligomerization is also required for normal poly(A) tail length control was unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Whether expanded PABPN1 forms canonical amyloid structures and what proteins are sequestered was unknown; biophysical studies showed antiparallel β-sheet amyloid-like fibrils from the expanded N-terminus, and expanded PABPN1 was shown to sequester hnRNP A1/A/B in inclusions in patient muscle.\",\n      \"evidence\": \"ThT fluorescence, CD spectroscopy, EM of recombinant expanded PABPN1; yeast two-hybrid, GST pull-down, co-IP, and immunofluorescence in patient tissue for hnRNP interactions\",\n      \"pmids\": [\"14627730\", \"12945950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether sequestration of hnRNPs functionally contributes to disease was not demonstrated\", \"Full inventory of sequestered factors was incomplete\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Where PABPN1 acts along the gene expression pathway was unclear; cryo-immunoEM showed it associates with RNA Pol II on chromatin, accompanies mRNPs to the nuclear pore, and is stripped during or after translocation, defining its life cycle on the transcript.\",\n      \"evidence\": \"Cryo-immunoelectron microscopy of Chironomus tentans Balbiani ring mRNPs at sequential stages\",\n      \"pmids\": [\"12749861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of PABPN1 stripping at the pore was unknown\", \"Whether this cotranscriptional recruitment mechanism is conserved in mammals was not directly shown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"PABPN1 was considered exclusively a nuclear polyadenylation factor; Drosophila genetics revealed an unexpected cytoplasmic role in shortening poly(A) tails of specific maternal mRNAs (oskar, cyclin B) together with CCR4, controlling protein levels and embryonic development.\",\n      \"evidence\": \"Genetic loss-of-function in Drosophila; poly(A) tail assays; genetic interaction with CCR4\",\n      \"pmids\": [\"16198293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this cytoplasmic deadenylation role is conserved in mammals was unknown at this time\", \"Direct physical interaction with CCR4 was not shown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether OPMD pathology is driven by polyalanine toxicity or by PABPN1's RNA-processing function was debated; Drosophila studies showed that muscle degeneration requires the RNA-binding domain but not the polyalanine tract, establishing that disease stems from dysregulated RNA processing.\",\n      \"evidence\": \"Transgenic Drosophila with PABPN1 domain-specific mutants; muscle degeneration and inclusion phenotyping\",\n      \"pmids\": [\"16642034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific RNA targets whose misprocessing drives muscle degeneration were not identified\", \"Whether the same principle applies in mammalian OPMD models was not confirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The structural basis for preferential interaction of expanded PABPN1 with chaperones was unknown; pull-down assays and MD simulations revealed that polyalanine expansion converts the disordered N-terminus to a stable helix, enhancing binding to Hsp70, PRMT1, and PRMT3, which are then sequestered in inclusions.\",\n      \"evidence\": \"Pull-down of expanded vs. WT PABPN1; immunofluorescence in OPMD patient muscle; molecular dynamics simulations\",\n      \"pmids\": [\"19641605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether sequestration of PRMTs has functional consequences for arginine methylation in muscle was not tested\", \"Structural model was based on simulation without experimental structure validation\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"How PABPN1 levels are maintained was unknown; a novel autoregulatory circuit was identified in which PABPN1 promotes retention of its own 3'-terminal intron by binding an A-rich element in the 3' UTR, targeting the unspliced pre-mRNA for Rrp6-dependent nuclear exosome decay.\",\n      \"evidence\": \"RT-PCR intron retention assays; PABPN1 and Rrp6 knockdown in human cells; RNA immunoprecipitation\",\n      \"pmids\": [\"25963658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this autoregulatory mechanism is disrupted in OPMD was not examined\", \"Quantitative contribution of this pathway vs. other regulatory circuits (HuR, circPABPN1) was not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Whether PABPN1 plays a direct role in splicing was uncertain; depletion experiments revealed that PABPN1 promotes splicing of a subset of post-transcriptionally excised terminal introns, requiring its RNA-binding and PAP-stimulatory activities, linking poly(A) tail addition to splicing commitment.\",\n      \"evidence\": \"PABPN1 RNAi in human cells; splicing assays; ChIP for splicing factor recruitment; domain mutant complementation\",\n      \"pmids\": [\"25896913\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of recruited splicing factors was not fully resolved at this stage\", \"Whether intron retention phenotypes in OPMD are direct consequences of this function was not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"PABPN1's interaction partners in muscle and feedback regulation of its own translation were poorly defined; MATR3 was identified as a co-regulator of APA and intron retention in skeletal muscle, while circPABPN1 was shown to compete with PABPN1 mRNA for HuR binding, suppressing PABPN1 translation.\",\n      \"evidence\": \"Co-IP/MS from mouse muscle (MATR3); HuR-RIP with circRNA sequencing; polysome profiling and competition assays\",\n      \"pmids\": [\"28977530\", \"28080204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MATR3-PABPN1 interaction is disrupted in OPMD was not fully resolved\", \"Stoichiometric relationship between circPABPN1 and PABPN1 mRNA in different tissues was unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"PABPN1's roles in oocyte biology and early embryonic development were unknown; conditional knockout revealed that PABPN1 drives NPAD formation through LLPS to stabilize oocyte transcripts (causing sterility when lost), and separately mediates cytoplasmic maternal mRNA clearance by recognizing uridylated tails and recruiting DIS3L2.\",\n      \"evidence\": \"Pabpn1 cKO in mouse oocytes with LLPS domain analysis and transcript stability assays; Pabpn1 KO embryos with RIP, uridylation assays, and DIS3L2 co-IP\",\n      \"pmids\": [\"36306357\", \"34904664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NPAD formation occurs in somatic cells was not determined\", \"How PABPN1 switches from nuclear poly(A)-binding to cytoplasmic uridylated-RNA recognition was mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The mechanism by which PABPN1 promotes terminal intron splicing was incomplete; TurboID proximity labeling and tethering experiments identified RBM26/RBM27 as direct PABPN1-recruited effectors that couple poly(A) tail presence to spliceosome engagement at last introns with weak 3' splice sites.\",\n      \"evidence\": \"PABPN1 knockdown + RNA-seq in HeLa; tethering to non-polyadenylated transcripts; TurboID-MS interactome; co-IP of RBM27 with domain mapping\",\n      \"pmids\": [\"37661812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RBM26/27 directly contacts spliceosomal components was not shown\", \"Contribution of this pathway to OPMD intron retention phenotypes was not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"How PABPN1 phase separation is regulated by interacting proteins was unknown; SNRPD2 was found to bind the EP domain, disrupt PABPN1 LLPS, and shift polyadenylation toward proximal sites, shortening 3' UTRs and promoting cancer cell proliferation.\",\n      \"evidence\": \"Co-IP of SNRPD2-PABPN1; LLPS assays with domain mutants; APA profiling; cancer cell functional assays\",\n      \"pmids\": [\"38811444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SNRPD2-mediated LLPS disruption occurs in normal tissues was not assessed\", \"Structural basis for EP domain interaction with SNRPD2 is lacking\", \"In vivo relevance in tumor models was not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: the structural basis of PABPN1 oligomeric particle assembly and how particle size signals polyadenylation termination; how PABPN1 switches between nuclear poly(A)-binding and cytoplasmic uridylated-RNA recognition; why OPMD pathology is restricted to specific muscles despite ubiquitous PABPN1 expression; and what the full complement of transcripts affected by PABPN1-dependent APA and terminal intron retention is in disease-relevant tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of PABPN1 oligomeric particle exists\", \"Muscle-specific vulnerability in OPMD remains mechanistically unexplained\", \"Genome-wide APA and splicing target maps in OPMD patient muscle are incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [1, 2, 10, 12, 21, 28, 29, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 17, 20, 21, 30]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [28, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3, 4, 8, 16, 28]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [2, 16, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [9, 29]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [8, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [1, 9, 17, 21, 29, 30]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [20, 22, 25]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [13, 27]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 5, 7, 12]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MATR3\",\n      \"RBM27\",\n      \"RBM26\",\n      \"DIS3L2\",\n      \"HNRNPA1\",\n      \"SNRPD2\",\n      \"PRMT1\",\n      \"ARIH2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}